EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Brief Introduction for the Dermatologist to a Novel Non-Dopaminergic Antipsychotic: Xanomeline-Trospium Chloride

Amelie Spangenberg, Eric L. Bean, Nicholas D. Brownstone, John Y. M. Koo

SKIN The Journal of Cutaneous Medicine · 10.11.2026 · 10 (6) · 3548-3550

DOI: 10.25251/s9beg853 ↗

Kurz gefasst

Fachartikel in der Zeitschrift SKIN The Journal of Cutaneous Medicine, online erschienen am 10.11.2026. Verfasst von Amelie Spangenberg und 3 weiteren Autor:innen. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Spangenberg, A., Bean, E. L., Brownstone, N. D., & Koo, J. Y. M. (2026). A Brief Introduction for the Dermatologist to a Novel Non-Dopaminergic Antipsychotic: Xanomeline-Trospium Chloride. SKIN The Journal of Cutaneous Medicine, 10(6), 3548-3550. https://doi.org/10.25251/s9beg853

Vancouver

Spangenberg A, Bean EL, Brownstone ND, Koo JYM. A Brief Introduction for the Dermatologist to a Novel Non-Dopaminergic Antipsychotic: Xanomeline-Trospium Chloride. SKIN The Journal of Cutaneous Medicine. 2026;10(6):3548-3550. doi:10.25251/s9beg853

BibTeX
@article{Spangenberg2026,
  author = {Spangenberg, Amelie and Bean, Eric L. and Brownstone, Nicholas D. and Koo, John Y. M.},
  title = {A Brief Introduction for the Dermatologist to a Novel Non-Dopaminergic Antipsychotic: Xanomeline-Trospium Chloride},
  journal = {SKIN The Journal of Cutaneous Medicine},
  year = {2026},
  volume = {10},
  number = {6},
  pages = {3548--3550},
  doi = {10.25251/s9beg853}
}
Kostenlos starten →